Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
12 Months Ended
Nov. 30, 2012
Nov. 30, 2011
Nov. 30, 2010
Revenues      
Sales of health and beauty aid products, net $ 53,169,022 $ 49,033,367 $ 50,345,213
Other income (Note 9) 606,653 478,522 466,429
Total Revenues 53,775,675 49,511,889 50,811,642
Costs and Expenses      
Cost of sales 23,219,051 20,450,468 21,808,009
Selling, general and administrative expenses 21,727,273 21,967,327 21,139,743
Advertising, cooperative and promotions 7,142,284 5,436,565 7,493,282
Research and development 769,637 714,565 619,147
(Recovery of) doubtful accounts (26,851) (11,135) (130,192)
Interest expense 299 860 4,033
Total 52,831,693 48,558,650 50,934,022
Advertising Litigation Expense       2,235,465
Total Costs and Expenses 52,831,693 48,558,650 53,169,487
Income (Loss) before Provision for (Benefit from) Income Taxes 943,982 953,239 (2,357,845)
Provision for (Benefit from) income taxes 478,530 461,541 (693,085)
Net Income (Loss) $ 465,452 $ 491,698 $ (1,664,760)
Weighted Average Shares Outstanding      
Basic 7,054,442 7,054,442 7,054,442
Diluted 7,054,442 7,054,442 7,054,442
Earnings (Loss) Per Common Share (Note 2):      
Basic $ 0.07 $ 0.07 $ (0.24)
Diluted $ 0.07 $ 0.07 $ (0.24)